Search

everythinglearnresearchcommunity

for

Search:↓

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Using dermoscopy improves diagnosis of scalp and hair disorders in children.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Lichen planopilaris patients often have other health conditions too.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Using sunscreen and moisturizers may increase the chance of developing Frontal fibrosing alopecia (FFA), but the exact reason why is still unclear.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

The patient responded well to treatment with no disease progression.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

Early diagnosis and personalized treatment can prevent damage from dissecting cellulitis after hair restoration surgery.

FFA in young women is often missed, and no single treatment works best.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Lichen planopilaris in men often affects the scalp, eyebrows, arms, legs, and beard, with many having family members with hair loss.